The implantable cardioverter defibrillator

Michael Glikson, Paul A. Friedman

Research output: Contribution to journalReview articlepeer-review

82 Scopus citations


Implantable cardioverter defibrillators (ICDs) have evolved from the treatment of last resort to the gold standard therapy for patients at high risk for ventricular tachyarrhythmias. High-risk patients include those who have survived life-threatening arrhythmias, and individuals with cardiac diseases who are at risk for such arrhythmias, but are symptomless. Use of an ICD will affect the patient's quality of life. Some drugs can substantially affect defibrillator function and efficacy, and possible drug-device interactions should be considered. Patients with ICDs may encounter cell phones, antitheft detectors, and many other sources of potential electromagnetic interference. In addition to treating ventricular tachyarrhythmias, new defibrillators provide full featured dual chamber pacing, and could treat atrial arrhythmias, and congestive heart failure by means of biventricular pacing.

Original languageEnglish (US)
Pages (from-to)1107-1117
Number of pages11
Issue number9262
StatePublished - Apr 7 2001

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'The implantable cardioverter defibrillator'. Together they form a unique fingerprint.

Cite this